June 20, 2026 06:00 AM EDT
Weekly
Biopharma’s LGBTQ+ leaders; Novo Nordisk hacked?; and more
Nicole DeFeudis
Max Gelman
Welcome back to another edition of Endpoints Weekly! The summer solstice arrives this weekend — the northern hemisphere will reach its maximum tilt toward the sun at 4:24 a.m. Eastern time ...
June 20, 2026 06:00 AM EDT
Weekly
Biopharma’s LGBTQ+ leaders; Novo Nordisk hacked?; and more
Nicole DeFeudis
Max Gelman

Pharmalittle: We're reading about hackers extorting Novo, an FDA about-face, and more

Novo security breach claimed by hacking groups seeking multi-million-dollar ransoms: reports

Pharmalittle: We're reading about another FDA reversal, pharma's M&A spree and much more

Sanofi swaps R&D leaders; Merck’s Prometheus deal pays dividends

Pharmalittle: We're reading about an FDA commissioner candidate, Germany's plans for drug prices, and more

ARCH-launched Neumora stops depression program

At BIO, a glimpse behind Lilly and Chai’s partnership

Welcome back to Endpoints Weekly! Don’t miss Ryan Cross’ deep dive into the paranoia caused by competition with China. Ryan…

Welcome back to Endpoints Weekly! This week, we opened nominations for our eighth annual Women in Biopharma report. We’re looking…

A cyber extortion group claimed to have stolen more than a terabyte of data from Novo Nordisk and said it is exploring selling…

Welcome back to another edition of Endpoints Weekly! My usual co-author Nicole DeFeudis was out this week on a much-deserved…

After disclosing a security breach last week concerning “a limited number of internal IT systems,” details on the cyber threat…

Welcome back to another edition of Endpoints Weekly. My usual colleague Nicole DeFeudis is out this week, so I’ve assembled the…